Operating Lease, Right-of-Use Asset in USD of RayzeBio, Inc. from Q4 2022 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: RayzeBio, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2022 to Q3 2023.
RayzeBio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2023 was $8,484,000.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

RayzeBio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2023	$8,484,000			30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q4 2022	$9,308,000			31 Dec 2022	10-Q	13 Nov 2023	2023	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.